<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00505505</url>
  </required_header>
  <id_info>
    <org_study_id>1781964</org_study_id>
    <nct_id>NCT00505505</nct_id>
  </id_info>
  <brief_title>Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy</brief_title>
  <official_title>Effects of Intensive Insulin Therapy on Mortality, Morbidity and Long Term Neurologic Outcome in Neurosurgical Intensive Care Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Strict glycemic control improves mortality and morbidity of patients admitted to the
      postoperative intensive care unit (ICU). The investigators would like to know if this therapy
      could improve the long term neurologic and cognitive outcomes of patients treated for acute
      subarachnoid hemorrhage with either a surgical or intravascular approach.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intensive Insulin Therapy and Strict Glycemic Control (80-120 mg/dL) Versus Standard Insulin
      Therapy in Neurosurgical Intensive Care Patients (Subarachnoid Hemorrhage, Traumatic Brain
      Injury, Intracranial Expanding Lesion): Safety, and Efficacy (Mortality, Morbidity, Long Term
      Neurologic Outcome).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2002</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Episodes of hypoglycemia</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infection rate</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasospasm rate</measure>
    <time_frame>during the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>6 months follow up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurologic status</measure>
    <time_frame>6 months follow up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Traumatic Brain Injury</condition>
  <condition>Intracranial Hemorrhage</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Insulin infusion rate titrated to maintain glycemia between 80 and 100 mg/dl</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Insulin infusion rate titrated to maintain glycemia between 80 and 220 mg/dl</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin (Actrapid)</intervention_name>
    <description>50 UI Actrapid diluted in 50 ml of saline</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subarachnoid hemorrhage

          -  Traumatic brain injury

          -  Intracranial hemorrhage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Federico Bilotta, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology, Critical Care and Pain Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Federico Bilotta, MD, PhD</last_name>
    <phone>39 339 33 708 22</phone>
    <email>bilotta@tiscali.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vincenzo Cuzzone</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Rome La Sapienza</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Federico Bilotta, MD, PhD</last_name>
      <email>bilotta@tiscali.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2007</study_first_submitted>
  <study_first_submitted_qc>July 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2007</study_first_posted>
  <last_update_submitted>August 6, 2008</last_update_submitted>
  <last_update_submitted_qc>August 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2008</last_update_posted>
  <keyword>Neurointensive care</keyword>
  <keyword>Intensive insulin infusion</keyword>
  <keyword>Hypoglycemia</keyword>
  <keyword>Postoperative Mortality</keyword>
  <keyword>Postoperative Morbidity</keyword>
  <keyword>Neurologic outcome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Intracranial Hemorrhages</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

